X We use cookies to analyze traffic and provide you with the best content. By continuing to browse our site, you agree to our use of cookie technology and our privacy policy. we are in social networks With the direct participation of Moscow State University. M.V. Lomonosov russian english PROGRAMMED AGING JONAH SKULACHEVA INVESTMENT PROJECT DEVELOPMENT METHOD STAGES OF PROJECT DEVELOPMENT RESULTS PUBLICATIONS PROJECT PARTICIPANTS QUESTION ANSWER CONTACTS September 5 , 2018 Innovations from Moscow State University enter the global market for biomedical technologies Mitotech, a resident of the MSU Science Park, organized by MSU scientists to implement the innovative Project "Practical Applications of Ionov Skulachev", announced the conclusion of an agreement with Essex Bio-Investments, part of the Essex Bio-Technology group of companies based in China (shares are traded on the main Hong Kong exchange, company code 1061). The agreement is aimed at the joint development and introduction of drugs based on "Ionov Skulachev" in China, the United States and other countries. 31 july 2018 New partner in the production of eye drops "Visomitin" The Mitotech company announces the beginning of cooperation with the biotechnological company FIRN M. Within the framework of the agreement, starting from July 2018, a dosage form will be produced at the FIRN M production complex, bottling and packaging of Vizomitin eye drops will be carried out. All news " RSS news " The most ambitious goal of our project is to create a drug that disrupts the aging program. Project participants More than 300 people from 40 organizations are involved in the project. From Moscow State University - 6 faculties, 2 research institutes, about 150 employees. REGULATIONS on the procedure for storing and protecting personal data for the website (Mitotech) skq-project.ru +7 (495) 939-59-45 Email info@skq-project.ru 2008 website development : © 2008-2014 Research Institute of Mitoengineering, Moscow State University